Pasithea Therapeutics exotic insider transaction detected

KTTA Stock  USD 0.87  0.04  4.82%   
About 75 percent of all Pasithea Therapeutics' investors are curious in acquiring. The analysis of the overall investor sentiment regarding Pasithea Therapeutics Corp suggests that a large number of traders are confidant. The current market sentiment, together with Pasithea Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Pasithea Therapeutics stock news signals to limit their universe of possible portfolio assets.
Filed transaction by Pasithea Therapeutics Cor officer. Unconventional Insider trading

Read at macroaxis.com
Pasithea insider trading alert for general transaction of stock option right to buy by Currie Graeme Martin, Chief Development Officer, on 3rd of July 2023. This event was filed by Pasithea Therapeutics Cor with SEC on 2023-07-03. Initial filing of beneficial ownership - SEC Form 3

Cash Flow Correlation

Pasithea Therapeutics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Pasithea Therapeutics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Pasithea Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Pasithea Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Pasithea Therapeutics Historical Investor Sentiment

Investor biases related to Pasithea Therapeutics' public news can be used to forecast risks associated with an investment in Pasithea. The trend in average sentiment can be used to explain how an investor holding Pasithea can time the market purely based on public headlines and social activities around Pasithea Therapeutics Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Pasithea Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pasithea Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Pasithea Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Pasithea Therapeutics.

Pasithea Therapeutics Fundamental Analysis

We analyze Pasithea Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pasithea Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pasithea Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Debt To Equity

Debt To Equity Comparative Analysis

Pasithea Therapeutics is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

Pasithea Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pasithea Therapeutics stock to make a market-neutral strategy. Peer analysis of Pasithea Therapeutics could also be used in its relative valuation, which is a method of valuing Pasithea Therapeutics by comparing valuation metrics with similar companies.

Peers

Pasithea Therapeutics Related Equities

ABVCABVC Biopharma   12.40   
0%
63.0%
INDPIndaptus Therapeutics   4.05   
0%
20.0%
KRONKronos Bio   2.79   
0%
14.0%
REVBRevelation Biosciences   2.52   
0%
12.0%
RNXTRenovoRx   1.92   
0%
9.0%
VRAXVirax Biolabs   1.90   
0%
9.0%
KZRKezar Life   0.24   
0%
1.0%
MNOVMediciNova   0.00   
0%
0%
QNRXQuoin Pharmaceuticals   1.13   
5.0%
0%
FBRXForte Biosciences   1.57   
8.0%
0%
KPRXKiora Pharmaceuticals   1.85   
9.0%
0%
NTRBWNutriband Warrant   19.50   
100.0%
0%

Complementary Tools for Pasithea Stock analysis

When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges